Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0858
-0.0002 (-0.23%)
Mar 26, 2026, 11:23 AM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 105.57 million as of March 26, 2026. Its market cap has decreased by -39.01% in one year.
Market Cap
105.57M
Enterprise Value
123.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 105.57M, a decrease of -86.24%. That is a compound annual growth rate of -48.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 105.57M | -7.92% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 101.23B |
| Coloplast | 95.85B |
| ALK-Abelló | 43.65B |
| ChemoMetec | 4.12B |
| BioPorto | 448.56M |
| ViroGates | 103.49M |
| Scandinavian Medical Solutions | 91.20M |